{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T04:21:00Z","timestamp":1787458860257,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004351","name":"Sultan Qaboos University","doi-asserted-by":"publisher","award":["IG\/MED\/BIOM\/25\/01"],"award-info":[{"award-number":["IG\/MED\/BIOM\/25\/01"]}],"id":[{"id":"10.13039\/501100004351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004351","name":"Sultan Qaboos University","doi-asserted-by":"publisher","award":["IG\/MED\/PATH\/21\/01"],"award-info":[{"award-number":["IG\/MED\/PATH\/21\/01"]}],"id":[{"id":"10.13039\/501100004351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04296-7","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:18:24Z","timestamp":1773130704000},"page":"3880-3896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing telomerase and Ki-67 protein expression in pre-invasive lesions and invasive cervical neoplasia with correlation to clinico-pathological parameters"],"prefix":"10.1007","volume":"28","author":[{"given":"Manal Masoud Musallam","family":"Al Awfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al Shifaa Ibrahim Said","family":"Al Wahaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Arafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"Al Badi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqaiya","family":"Al Shamsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Al Hinai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samya","family":"Al Husaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afrah","family":"Al Rashdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asem","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1787-1908","authenticated-orcid":false,"given":"Mohamed","family":"Mabruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"4296_CR1","unstructured":"World Cancer Research Fund International. Worldwide cancer data | World Cancer Research Fund International. WCRF International, March. 2022. Accessed 7 Mar 2024."},{"key":"4296_CR2","unstructured":"World Health Organization. Cervical cancer. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer. Accessed 15 Apr 2024."},{"key":"4296_CR3","unstructured":"American Cancer Society. Cervical Cancer Statistics | Key Facts About Cervical Cancer. [cited 2026 Jan 11]. https:\/\/www.cancer.org\/cancer\/types\/cervical-cancer\/about\/key-statistics.html"},{"key":"4296_CR4","unstructured":"ICO\/IARC Information Centre on HPV and Cancer. Oman: Human Papillomavirus and Related Cancers, Fact Sheet 2023, Fact Sheet. 2023."},{"issue":"3","key":"4296_CR5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.31557\/APJCP.2021.22.3.775","volume":"22","author":"T Al Yahyai","year":"2021","unstructured":"Al Yahyai T, Al Raisi M, Al Kindi R. Knowledge, attitudes, and practices regarding cervical cancer screening among Omani women attending primary healthcare centers in Oman: a cross-sectional survey. Asian Pac J Cancer Prevent: APJC. 2021;22(3):775\u201383. https:\/\/doi.org\/10.31557\/APJCP.2021.22.3.775.","journal-title":"Asian Pac J Cancer Prevent: APJC"},{"key":"4296_CR6","unstructured":"National Cancer Institute. What is cervical cancer?\u2014NCI. 2023. https:\/\/www.cancer.gov\/types\/cervical Accessed 19 Apr 2024."},{"key":"4296_CR7","unstructured":"Definition of transformation zone - NCI Dictionary of Cancer Terms \u2013 NCI. 2011. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/transformation-zone. Accessed 6 Mar 2025."},{"key":"4296_CR8","unstructured":"Canadian Cancer Society. Precancerous conditions of the cervix, Canadian Cancer Society. 2015. https:\/\/cancer.ca\/en\/cancer-information\/cancer-types\/cervical\/what-is-cervical-cancer\/precancerous-conditions. Accessed 19 Dec 2024."},{"key":"4296_CR9","unstructured":"American Cancer Society. What is cervical cancer? | Types of cervical cancer. 2023. https:\/\/www.cancer.org\/cancer\/types\/cervical-cancer\/about\/what-is-cervical-cancer.html. Accessed 19 Apr 2024."},{"issue":"2","key":"4296_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/aje\/kwn036","volume":"168","author":"J Koshiol","year":"2008","unstructured":"Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol. 2008;168(2):123\u201337. https:\/\/doi.org\/10.1093\/aje\/kwn036.","journal-title":"Am J Epidemiol"},{"key":"4296_CR11","unstructured":"National Cancer Institute. Cervical cancer causes, risk factors, and prevention - NCI. 2023. https:\/\/www.cancer.gov\/types\/cervical\/causes-risk-prevention. Accessed 19 Apr 2024."},{"issue":"5","key":"4296_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"22","key":"4296_CR13","doi-asserted-by":"publisher","first-page":"12571","DOI":"10.3390\/ijms222212571","volume":"22","author":"LV Volkova","year":"2021","unstructured":"Volkova LV, Pashov AI, Omelchuk NN. Cervical carcinoma: oncobiology and biomarkers. Int J Mol Sci. 2021;22(22):12571. https:\/\/doi.org\/10.3390\/ijms222212571.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4296_CR14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/jcp.51.10.716","volume":"51","author":"PJ Van Diest","year":"1998","unstructured":"Van Diest PJ, Brugal G, Baak JP. Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol. 1998;51(10):716\u201324. https:\/\/doi.org\/10.1136\/jcp.51.10.716.","journal-title":"J Clin Pathol"},{"key":"4296_CR15","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.4317\/medoral.18573","volume":"2013","author":"R Bologna-Molina","year":"2013","unstructured":"Bologna-Molina R, Mosqueda-Taylor A, Molina-Frechero N, Mori-Estevez AD, Sanchez-Acuna G. Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors. Med Oral Patol Oral Cirugia Bucal. 2013;2013:e174\u20139. https:\/\/doi.org\/10.4317\/medoral.18573.","journal-title":"Med Oral Patol Oral Cirugia Bucal"},{"issue":"4","key":"4296_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.20892\/j.issn.2095-3941.2016.0066","volume":"13","author":"AS Nahed","year":"2016","unstructured":"Nahed AS, Shaimaa MY. Ki-67 as a prognostic marker according to breast cancer molecular subtype. Cancer Biol Med. 2016;13(4):496. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2016.0066.","journal-title":"Cancer Biol Med"},{"issue":"10","key":"4296_CR17","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1158\/0008-5472.CAN-16-0707","volume":"77","author":"M Sobecki","year":"2017","unstructured":"Sobecki M, Mrouj K, Colinge J, Gerbe F, Jay P, Krasinska L, et al. Cell-cycle regulation accounts for variability in Ki-67 expression levels. Cancer Res. 2017;77(10):2722\u201334. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0707.","journal-title":"Cancer Res"},{"issue":"3","key":"4296_CR18","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/annonc\/mdq732","volume":"22","author":"W Jonat","year":"2011","unstructured":"Jonat W, Arnold N. Is the Ki-67 labelling index ready for clinical use? Ann Oncol. 2011;22(3):500\u20132. https:\/\/doi.org\/10.1093\/annonc\/mdq732.","journal-title":"Ann Oncol"},{"issue":"7","key":"4296_CR19","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/1097-0347(200010)22:7<658::AID-HED3>3.0.CO;2-A","volume":"22","author":"MA Gonzalez-Moles","year":"2000","unstructured":"Gonzalez-Moles MA, Ruiz-Avila I, Rodriguez-Archilla A, Martinez-Lara I. Suprabasal expression of Ki-67 antigen as a marker for the presence and severity of oral epithelial dysplasia. Head Neck. 2000;22(7):658\u201361. https:\/\/doi.org\/10.1002\/1097-0347(200010)22:7%3c658::AID-HED3%3e3.0.CO;2-A.","journal-title":"Head Neck"},{"issue":"17","key":"4296_CR20","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.3390\/cancers13174455","volume":"202113","author":"MG Davey","year":"2021","unstructured":"Davey MG, Hynes SO, Kerin MJ, Miller N, Lowery AJ. Ki-67 as a prognostic biomarker in invasive breast cancer. Cancers. 2021;202113(17):4455. https:\/\/doi.org\/10.3390\/cancers13174455.","journal-title":"Cancers"},{"issue":"11","key":"4296_CR21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/jclinpath-2018-205271","volume":"71","author":"M Van Zummeren","year":"2018","unstructured":"Van Zummeren M, Leeman A, Kremer WW, Bleeker MCG, Jenkins Van De Sandt D, Meijer CJLM. Three-tiered score for Ki-67 and p16 ink4a improves accuracy and reproducibility of grading CIN lesions. J Clin Pathol. 2018;71(11):981\u20138. https:\/\/doi.org\/10.1136\/jclinpath-2018-205271.","journal-title":"J Clin Pathol"},{"issue":"3","key":"4296_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1128\/MMBR.66.3.407-425.2002","volume":"66","author":"YS Cong","year":"2002","unstructured":"Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev. 2002;66(3):407\u201325. https:\/\/doi.org\/10.1128\/MMBR.66.3.407-425.2002.","journal-title":"Microbiol Mol Biol Rev"},{"key":"4296_CR23","unstructured":"National Human Genome Research Institute. Telomere. 2024. https:\/\/www.genome.gov\/genetics-glossary\/Telomere. Accessed 17 Apr 2024."},{"issue":"1","key":"4296_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/MCO.0b013e32834121b1","volume":"14","author":"MA Shammas","year":"2011","unstructured":"Shammas MA. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care. 2011;14(1):28\u201334. https:\/\/doi.org\/10.1097\/MCO.0b013e32834121b1.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"33","key":"4296_CR25","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","volume":"1997","author":"J Shay","year":"1990","unstructured":"Shay J, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer (Oxford, England). 1990;1997(33):787\u201391. https:\/\/doi.org\/10.1016\/S0959-8049(97)00062-2.","journal-title":"Eur J Cancer (Oxford, England)"},{"issue":"1","key":"4296_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0324-x","volume":"8","author":"MA Jafri","year":"2016","unstructured":"Jafri MA, Ansari SA, Alqahtani MH, Shay JW. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Med. 2016;8(1):69. https:\/\/doi.org\/10.1186\/s13073-016-0324-x.","journal-title":"Genome Med"},{"issue":"1","key":"4296_CR27","first-page":"25","volume":"151","author":"SK Anderson","year":"1997","unstructured":"Anderson SK, Ihle J, Billman L, Goff B, Greer B, Tamimi H, et al. Telomerase activation in cervical cancer. Am J Pathol. 1997;151(1):25\u201331.","journal-title":"Am J Pathol"},{"key":"4296_CR28","unstructured":"National Cancer Institute. Cervical Cancer Prognosis and Survival Rates, National Cancer Institute. Cancer.gov. 2023. https:\/\/www.cancer.gov\/types\/cervical\/survival. Accessed 1 Jan 2024."},{"issue":"4","key":"4296_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000545229","volume":"92","author":"F Al Hinai","year":"2025","unstructured":"Al Hinai F, Al Shamsi R, Al Husaini S, Al Rashdi A, Arafa M. The role of cytokeratin 7 and cytokeratin 19 immunohistochemistry in the evaluation of human papillomavirus-induced cervical squamous precursor epithelial lesions. Pathobiology. 2025;92(4):216\u201323. https:\/\/doi.org\/10.1159\/000545229.","journal-title":"Pathobiology"},{"issue":"S23","key":"4296_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/jcb.240590910","volume":"59","author":"CP Crum","year":"1995","unstructured":"Crum CP, McLachlin CM. Cervical intraepithelial neoplasia. J Cell Biochem. 1995;59(S23):71\u20139. https:\/\/doi.org\/10.1002\/jcb.240590910.","journal-title":"J Cell Biochem"},{"issue":"1","key":"4296_CR31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34155","volume":"15","author":"DR Priyanka","year":"2023","unstructured":"Priyanka DR, Arunachalam S, Amitkumar K, John JJ, Sudalaimuthu M. An immunohistochemical study on Ki-67 expression in squamous cell carcinomas of cervix with clinicopathological correlation. Cureus. 2023;15(1):e34155. https:\/\/doi.org\/10.7759\/cureus.34155.","journal-title":"Cureus"},{"issue":"3","key":"4296_CR32","doi-asserted-by":"publisher","first-page":"971","DOI":"10.4103\/ijo.IJO_1342_21","volume":"70","author":"P Jayaraj","year":"2022","unstructured":"Jayaraj P, Sen S, Saxena K, Gupta J, Vats P, Kashyap S, et al. Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma. Indian J Ophthalmol. 2022;70(3):971\u20135. https:\/\/doi.org\/10.4103\/ijo.IJO_1342_21.","journal-title":"Indian J Ophthalmol."},{"issue":"11","key":"4296_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1607-551X(09)70350-X","volume":"22","author":"S Yang","year":"2006","unstructured":"Yang S, Yuan SF, Yeh Y, Hung S, Wu M, Su J, et al. Positive association between STAT3 and Ki\u201067 in cervical intraepithelial neoplasia. Kaohsiung J Med Sci. 2006;22(11):539\u201346. https:\/\/doi.org\/10.1016\/S1607-551X(09)70350-X.","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"4296_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5146\/tjpath.2016.01373","volume":"33","author":"A Mitildzans","year":"2017","unstructured":"Mitildzans A, Arechvo A, Rezeberga D, Isajevs S. Expression of p63, p53 and ki-67 in patients with cervical intraepithelial neoplasia. Turk J Pathol. 2017;33(1):9\u201316. https:\/\/doi.org\/10.5146\/tjpath.2016.01373.","journal-title":"Turk J Pathol"},{"issue":"2","key":"4296_CR35","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3892\/ol.2019.10430","volume":"18","author":"Q Shi","year":"2019","unstructured":"Shi Q, Xu L, Yang R, Meng Y, Qiu L. Ki\u201167 and P16 proteins in cervical cancer and precancerous lesions of young women and the diagnostic value for cervical cancer and precancerous lesions, Oncology Letters. Oncol Lett. 2019;18(2):1351\u20135. https:\/\/doi.org\/10.3892\/ol.2019.10430.","journal-title":"Oncol Lett"},{"issue":"8","key":"4296_CR36","first-page":"4109","volume":"11","author":"X Zhang","year":"2018","unstructured":"Zhang X, Shen D. p16INK4a and Ki-67 measurement predict progression of cervical low-grade squamous intraepithelial lesion. Int J Clin Exp Pathol. 2018;11(8):4109\u201316.","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"4296_CR37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40291-018-0336-x","volume":"22","author":"A Pa\u0144czyszyn","year":"2018","unstructured":"Pa\u0144czyszyn A, Boniewska-Bernacka E, G\u0142\u0105b G. Telomeres and telomerase during human papillomavirus-induced carcinogenesis. Mol Diagn Ther. 2018;22(4):421.","journal-title":"Mol Diagn Ther"},{"issue":"3","key":"4296_CR38","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0002-9440(10)65627-1","volume":"153","author":"K Nakano","year":"1998","unstructured":"Nakano K, Watney E, McDougall JK. Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am J Pathol. 1998;153(3):857\u201364. https:\/\/doi.org\/10.1016\/S0002-9440(10)65627-1.","journal-title":"Am J Pathol"},{"issue":"5","key":"4296_CR39","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1136\/ijgc-00009577-200609000-00023","volume":"16","author":"PH Wang","year":"2006","unstructured":"Wang PH, Ko JL. Implication of human telomerase reverse transcriptase in cervical carcinogenesis and cancer recurrence. Int J Gynecol Cancer. 2006;16(5):1873\u20139. https:\/\/doi.org\/10.1136\/ijgc-00009577-200609000-00023.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"4296_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1535-6108(02)00183-69","volume":"2","author":"YR Seger","year":"2002","unstructured":"Seger YR, Garc\u00eda-Cao M, Piccinin S, Cunsolo CL, Doglioni C, Blasco MA, et al. Transformation of normal human cells in the absence of telomerase activation. Cancer Cell. 2002;2(5):401\u201313. https:\/\/doi.org\/10.1016\/S1535-6108(02)00183-69.","journal-title":"Cancer Cell"},{"issue":"1","key":"4296_CR41","doi-asserted-by":"publisher","first-page":"e52989","DOI":"10.1371\/journal.pone.0052989","volume":"8","author":"C Singhapol","year":"2013","unstructured":"Singhapol C, Pal D, Czapiewski R, Porika M, Nelson G, Saretzki GC. Mitochondrial telomerase protects cancer cells from nuclear DNA damage and apoptosis. PLoS ONE. 2013;8(1):e52989. https:\/\/doi.org\/10.1371\/journal.pone.0052989.","journal-title":"PLoS ONE"},{"key":"4296_CR42","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_00000254","author":"EM Fabricius","year":"2009","unstructured":"Fabricius EM. Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues. Int J Oncol. 2009. https:\/\/doi.org\/10.3892\/ijo_00000254.","journal-title":"Int J Oncol"},{"issue":"44","key":"4296_CR43","doi-asserted-by":"publisher","first-page":"7441","DOI":"10.1038\/sj.onc.1207527","volume":"23","author":"A Zhang","year":"2004","unstructured":"Zhang A, Wang J, Zheng B, Fang X, \u00c5ngstr\u00f6m T, Liu C, et al. Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix. Oncogene. 2004;23(44):7441\u20137. https:\/\/doi.org\/10.1038\/sj.onc.1207527.","journal-title":"Oncogene"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04296-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04296-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04296-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T03:20:33Z","timestamp":1787455233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04296-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["4296"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04296-7","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approval for this study was obtained from the research ethics committees of Sultan Qaboos University Hospital (REF. NO. SQU-EC\/ 329\/2021 MREC #2366) and the Ministry of Health (MoH\/CSR\/21\/24333).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}